Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
36
MDLV Quote, Financials, Valuation and Earnings
Last price:
$25.89
Seasonality move
:
3.92%
Day range:
$25.75 - $25.93
52-week range:
$23.79 - $27.67
Dividend yield:
3%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
62.4K
Avg. volume:
--
1-year change:
9.22%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Dividend Data
Dividend yield
3%
Sector average: 0%
Annualized payout
$0.00
Paid quarterly
Payout ratio
3%
EPS --
Dividend increase track record
0 years
Most Recent Dividend Payouts
Ex-dividend date
September 27
88 days ago
Ex-dividend amount
$0.18
Payment date
September 30
85 days ago
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
| Declaration Date | Ex-Dividend Date | Payable Date | Record Date | Amount |
|---|---|---|---|---|
| 02/07/2024 | 09/27/2024 | 09/30/2024 | 09/27/2024 | $0.18 |
| 02/07/2024 | 06/27/2024 | 06/28/2024 | 06/27/2024 | $0.19 |
| 02/07/2024 | 03/26/2024 | 03/28/2024 | 03/27/2024 | $0.18 |
| 12/19/2023 | 12/20/2023 | 12/22/2023 | 12/21/2023 | $0.23 |
| 09/26/2023 | 09/27/2023 | 09/29/2023 | 09/28/2023 | $0.26 |
| 06/27/2023 | 06/28/2023 | 06/30/2023 | 06/29/2023 | $0.08 |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
